Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preventing Childhood Asthma Using Prophylactic House Dust Mite Allergen Immunotherapy

NCT05113394 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT05113394
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05113394 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preventing Childhood Asthma Using Prophylactic House Dust Mite Allergen Immunotherapy
Lead sponsor
Boston Children's Hospital
Phase
Phase 2
Overall status
Withdrawn
Start date
February 1, 2027
Completion date
August 1, 2029
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

allergy, asthma